China Yongxin Pharmaceuticals Inc. began in 1993 as Changchun Yongxin Dirui Medical Co., Ltd. (Yongxin), a wholesale drug distributor. The Company’s products include Chinese traditional medicines, chemical preparations, natural health products, cosmetics, and medical equipment. On May 20, 2008, China Yongxin Pharmaceuticals Inc. announced that they completed their reverse merger with Nutradyne Group, Inc. To reflect their true business, they changed their corporate name to China Yongxin Pharmaceuticals Inc. and their ticker symbol to “OTCBB: CYXN.” Today, they are a leading manufacturer, distributor, and retailer of pharmaceuticals in Northeastern China.

China Yongxin began retail operations in 2001. In 2005, the Company acquired China’s Jilin Province franchise rights from Medicine Shoppe China Inc. The Company became a rapidly growing medicine distributor and retailer by the end of 2007. Currently, they have five subsidiaries including 93 chain pharmacies.

In November, China Yongxin Pharmaceuticals, Inc. announced financial results for the third quarter ended September 30,

China North East Petroleum Holdings Limited, a pioneer in China’s oilfield drilling and production industry, today announced a spectacular increase in revenue and net income for the third quarter of 2008.

Total sales for the third quarter increased 227% over the same quarter last year to $19.7 million. The jump was due to an increase in crude oil production, and the price received for crude oil from PetroChina (PTR), the company’s sole customer. Crude oil production doubled to 172,730 barrels over the same quarter last year. The production boost was attributed to refracturing improvements, and the implementation of water injection technology, improving the efficiency of existing oil wells, together with the addition of 30 new wells drilled during the third quarter.

Gross profit also soared for the quarter, increasing 241%, to $9.2 million, with net income jumping 229% to $4.0 million.

Quarterly results boosted nine-month sales figures from $11.8 million last